Microsemi CRP Automated Hematology Analyzer Evaluated
By LabMedica International staff writers Posted on 05 Feb 2015 |
Complete blood counts (CBC) including white blood cell count (WBC) differentials and C-reactive protein (CRP) have been frequently utilized as the biomarkers for inflammatory diseases such as bacterial infection.
An automated hematology analyzer has been developed which can simultaneously measure CBC including three-part WBC differential (3-Diff) and CRP using ethylenediaminetetraacetic acid dipotassium salt dihydrate (EDTA-2K) anticoagulated whole blood without centrifugation for serum preparation.
Scientists at HORIBA Medical (Kyoto, Japan) used the company’s automated hematology analyzer, The Microsemi CRP, which is equipped with the electrical resistance method for CBC with 3-Diff of granulocytes (GRA) including neutrophils eosinophils and basophils, lymphocytes (LYM), and monocytes (MON). CRP is measured with the latex immune turbidimetry method following the prompt hemolyzation of EDTA-2K anticoagulated whole blood. The obtained value is then converted into plasma concentration according to hematocrit (HCT %) of respective sample to finally provide as ‘whole blood CRP.’
Correlation tests for the Microsemi CRP were compared with those of Micros CRP200, a preceding Horiba Medical model, and also those of the ADVIA 2120i (Siemens; Munich, Germany) routine hematology analyzer. The results of fresh whole blood and serum CRP obtained using Micros CRP200 were compared with those of serum CRP obtained using HITACHI 7600 routine analyzer (Tokyo, Japan).
The CBC data examined using Microsemi CRP showed excellent correlation with the previous model, Micros CRP200and also those obtained using the routine analyzer, ADVIA 2120i. In regards to the 3-Diff, both GRA (%) and LYM (%) showed the excellent correlation coefficient between Microsemi CRP and Micros CRP200 as well as ADVIA 2120i. (MON (%) showed good correlation between Microsemi CRP and Micros CRP200, but lower correlation between Microsemi CRP and ADVIA 2120. CRP data showed the good correlation with HITACHI 7600 and Micros CRP200.
The authors concluded that Microsemi CRP was a convenient laboratory analyzer which could provide the clinically reliable data about CBC including 3-Diff and CRP using only 18 μL whole blood within approximately four minutes. Therefore, Microsemi CRP seemed suitable in the setting of point of care testing (POCT) for the patients with inflammatory diseases such as bacterial infection, especially for pediatric ones in whom sufficient volume of samples necessary to simultaneous measurement of CBC including WBC Diff and CRP using the routine analyzers. The study was first published online on December 11, 2014, in the International Journal of Laboratory Hematology.
Related Links:
HORIBA Medical
Siemens
HITACHI
An automated hematology analyzer has been developed which can simultaneously measure CBC including three-part WBC differential (3-Diff) and CRP using ethylenediaminetetraacetic acid dipotassium salt dihydrate (EDTA-2K) anticoagulated whole blood without centrifugation for serum preparation.
Scientists at HORIBA Medical (Kyoto, Japan) used the company’s automated hematology analyzer, The Microsemi CRP, which is equipped with the electrical resistance method for CBC with 3-Diff of granulocytes (GRA) including neutrophils eosinophils and basophils, lymphocytes (LYM), and monocytes (MON). CRP is measured with the latex immune turbidimetry method following the prompt hemolyzation of EDTA-2K anticoagulated whole blood. The obtained value is then converted into plasma concentration according to hematocrit (HCT %) of respective sample to finally provide as ‘whole blood CRP.’
Correlation tests for the Microsemi CRP were compared with those of Micros CRP200, a preceding Horiba Medical model, and also those of the ADVIA 2120i (Siemens; Munich, Germany) routine hematology analyzer. The results of fresh whole blood and serum CRP obtained using Micros CRP200 were compared with those of serum CRP obtained using HITACHI 7600 routine analyzer (Tokyo, Japan).
The CBC data examined using Microsemi CRP showed excellent correlation with the previous model, Micros CRP200and also those obtained using the routine analyzer, ADVIA 2120i. In regards to the 3-Diff, both GRA (%) and LYM (%) showed the excellent correlation coefficient between Microsemi CRP and Micros CRP200 as well as ADVIA 2120i. (MON (%) showed good correlation between Microsemi CRP and Micros CRP200, but lower correlation between Microsemi CRP and ADVIA 2120. CRP data showed the good correlation with HITACHI 7600 and Micros CRP200.
The authors concluded that Microsemi CRP was a convenient laboratory analyzer which could provide the clinically reliable data about CBC including 3-Diff and CRP using only 18 μL whole blood within approximately four minutes. Therefore, Microsemi CRP seemed suitable in the setting of point of care testing (POCT) for the patients with inflammatory diseases such as bacterial infection, especially for pediatric ones in whom sufficient volume of samples necessary to simultaneous measurement of CBC including WBC Diff and CRP using the routine analyzers. The study was first published online on December 11, 2014, in the International Journal of Laboratory Hematology.
Related Links:
HORIBA Medical
Siemens
HITACHI
Read the full article by registering today, it's FREE!

Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!

Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Hematology News
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read more
Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes
HIV diagnostic methods have traditionally relied on detecting HIV-specific antibodies, which typically appear weeks after infection. This delayed detection has hindered early diagnosis, complicating patient... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read more
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more